UNSPSC 51461536: Eupatorium

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifiers DG4F8T839X and M9VVZ08EKQ (leaf and root), and which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 35980 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Asterales, Family Asteraceae, Genus Eupatorium L. (thoroughwort), Species Eupatorium perfoliatum L., more commonly known as EUPATORIUM.

UNSPSC 51461536 Eupatorium is a Commodity code for specific botanical pharmaceutical ingredients. State and local procurement under this code centers on generic and over-the-counter pharmaceutical products supplied through cooperative purchasing agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body visible in current activity, procuring manufacturers and distributors to supply comprehensive generic pharmaceutical and OTC product lines to participating state and local government facilities across multiple states including Oregon. Vendors must maintain current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance, establish relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), and hold substantial insurance coverage including $5,000,000 commercial general liability per occurrence and $2,000,000 network security and privacy liability.

MMCAP issued a Request for Proposal (S1070000015802) on January 20, 2026, due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026, with a two-year initial term and optional extensions through June 30, 2028. Evaluation is weighted heavily on price competitiveness (75 percent), with the remaining 25 percent distributed across fixed pricing, administrative fee format compliance, EDI capability, and pricing flexibility options including flat price, net price formats (NF30, NF60, NF90), or WAC-minus structures. All products must be available in the marketplace by May 15, 2026, with expiration dates of at least one year from manufacture and a minimum six-month shelf life. Vendors must submit detailed product specifications including National Drug Codes (NDC), SKUs, UPCs, and manufacturing locations through the ePro procurement system, and all awards carry a 3 percent administrative fee on contract purchases with performance penalties ranging from $200 to $1,500 per violation.